Premium
Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix
Author(s) -
Lüleci Güven,
Sakizli Meral,
Günalp Altan,
Erkan Ilhan,
Remzi Dogan
Publication year - 1981
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930160405
Subject(s) - medicine , cervix , urology , prostate , urinary system , gynecology , antibody , cancer , carcinoma , immunology
In the blood samples obtained from a total of 68 patients with cancers of the urinary bladder, prostate, and cervix, who applied to the Departments of Urology, Obstetrics, and Gynecology of Hacettepe Medical Faculty, neutralizing antibodies were sought for against herpes simplex type 2 by neutralization test. The same test was applied to 35 control patients with no known malignancies. In contrast to the presence of the antibody in 62.86% of the control subjects, this ratio was 90.70% in patients with cancer of the urinary bladder, 87.50% in those with prostatic carcinoma, and 88.89% in those with cancer of the cervix.